113 results
S-3ASR
IBRX
ImmunityBio Inc
17 Apr 24
Automatic shelf registration
5:24pm
that he or she was a director, executive officer, employee or agent of the corporation or is or was serving at the request of a corporation against … report pursuant to Section 13(a) or 15(d) of the Exchange Act (and, where applicable, each filing of an employee benefit plan’s annual report pursuant
S-3ASR
EX-4.3
IBRX
ImmunityBio Inc
17 Apr 24
Automatic shelf registration
5:24pm
and exceptions. The counsel may be an employee of or counsel to the Company.
“person” means any individual, corporation, partnership, joint venture … or indemnify against any loss or liability incurred by the Trustee or by any officer, director, employee, shareholder or agent of the Trustee through
424B5
qg9jfoc8gr5
24 Jul 23
Prospectus supplement for primary offering
5:12pm
8-K
EX-10.1
py4xy2 f403875je9a
21 Jul 23
ImmunityBio Announces Execution of $40 Million Equity Financing with Institutional Investors
6:04am
8-K
EX-1.1
h3jrisd
21 Jul 23
ImmunityBio Announces Execution of $40 Million Equity Financing with Institutional Investors
6:04am
8-K
EX-10.1
m3rac
12 Dec 22
ImmunityBio Announces $157 Million Financing From Nant and Institutional Investor
9:07am
8-K
EX-1.1
a02mh6 hyd7q6g
12 Dec 22
ImmunityBio Announces $157 Million Financing From Nant and Institutional Investor
9:07am
424B5
lmmkw89njy5s0
12 Dec 22
Prospectus supplement for primary offering
8:08am